New anti-HIV drug gets FDA approval

Published: Jan. 21, 2008 at 10:58 AM

WASHINGTON, Jan. 21 (UPI) -- The U.S. Food and Drug Administration has approved etravirine tablets to treat the human immunodeficiency virus in adults not helped by other drugs.

Etravirine, sold under the trade name Intelence, is a non-nucleoside reverse transcriptase inhibitor, or NNRTI, that helps block an enzyme, which HIV needs to multiply.

"This is another significant new product for many HIV-infected patients who are NNRTI-resistant and whose infections are not responding to currently available medications," said Dr. Debra Birnkrant, director of the FDA's Division of Antiviral Products.

When used with other active anti-HIV medicines, etravirine reduces the amount of HIV in the blood and increases white blood cells that help fight other infections. In addition, the FDA said etravirine might reduce the risk of death or infections that can occur with a weakened immune system.

Etravirine is distributed by Tibotec Therapeutics, a division of Ortho Biotech Products L.P. of Bridgewater, N.J.

© 2008 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
What makes holidays special can kill pets
NHL: Chicago 7, San Jose 2
NBA: Portland 93, New Jersey 83
NBA: Sacramento 111, New York 97
COL BKB: Kentucky 73, Stanford 65 (OT)
NHL: Anaheim 3, Carolina 2
NHL: Los Angeles 3, Edmonton 1
fark
The six most horrific lessons ever taught in elementary school
Thirty-two percent of American men are obviously watching Alton Brown more than the Dallas Cowboys...
Old and Busted: Crashing a wedding reception. New Hotness: Crashing Obama's first State Dinner
Truthers won't be getting much sleep this week after Wikileaks posts 573,000 pager messages from...
Photoshop this Unisphere
Coño man, it has been 10 years since Elián touch our hearts, Ft Lauderdale